Description
Retatrutide — Triple Receptor Agonist Research Peptide
Retatrutide is a next-generation multi-agonist peptide designed to interact with GLP-1, GIP, and glucagon receptors, offering expanded utility across advanced laboratory research models.
Specifications
Form: Lyophilized powder
Storage: Store in a cool, dry environment away from direct light and moisture
Intended Use
This compound is intended strictly for qualified laboratory research and controlled scientific study.
Not for human or veterinary use. Not to be used as a drug, cosmetic, food additive, or household product.
Research-Only Disclaimer
This product is supplied exclusively for in vitro research and educational purposes.
It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
All purchasers must be qualified professionals, institutions, or laboratories with knowledge of proper handling and research protocols.
Terms of Sale
By purchasing from ManaWell Research, you acknowledge and agree that:
You are a qualified professional conducting lawful scientific research
You understand this compound is not for human consumption or any non-research use
ManaWell Research assumes no responsibility for misuse, mishandling, or improper application of this material
There are no reviews yet.